Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Cerri KH, Knapp M, Fernandez JL. Decision making by NICE: examining the influences of evidence, process and context. Health Econ Policy Law. 2014;9:119–41.
2. Maison P, Zanetti L, Solesse A, Bouvenot G, Massol J, ISPEP group of the French National Authority for Health. The public health benefit of medicines: how it has been assessed in France? The principles and results of five years’experience. Health Policy. 2013;112:273–84.
3. Deutscher Bundestag. [Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477, letzte Änderung durch Artikel 3 des Gesetzes vom 20. Dezember 2012 (BGBI. I S. 2781))]. 1988.
https://www.gesetze-im-internet.de/bundesrecht/sgb_5/gesamt.pdf
. Accessed 15 Sept 2016.
4. Ruof J, Schwartz FW, Schulenburg JM, Dintsios CM. Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introductin the new AMNOG legislation. Eur J Health Econ. 2014;15:577–89.
5. Ludwig S, Dintsios CM. Arbitration board setting reimbursement amounts for pharmaceutical innovations in Germany when Price negations between payers and manufacturers fail: an empirical analysis of 5 Years' experience. Value Health. 2016;19:1016–25.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献